CONMED Corporation CNMD
50.63 USD -0.14 (-0.28%)
Nov 12, 2026, 12:45 PM EST
50.22 Day range 51.31
31.44 52-week range 54.80
- YTD
- +24.70%
- 1 year
- +16.23%
News
zacks.com Here's Why You Should Retain CONMED Stock in Your Portfolio for Now CONMED's AirSeal, Buffalo Filter and BioBrace platforms offer growth opportunities, while rising robotic procedures and ASC adoption support its long-term prospects despite tariff and operational…
benzinga.com JP Morgan Maintains Neutral on Conmed, Raises Price Target to $50 JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and raises the price target from $45 to $50.
benzinga.com Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $49 Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $46 to $49.
benzinga.com Conmed Q3 2026 Earnings Call Transcript Conmed (NYSE:CNMD) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Conmed Raises FY2026 Adj EPS Guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 Est; Narrows FY2026 Sales Guidance from $1.358B-$1.373B to $1.360B-$1.366B vs $1.366B Est Conmed (NYSE:CNMD) raises FY2026 Adj EPS guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 analyst estimate. Narrows FY2026 sales outlook from $1.358 billion-$1.373 billion to $1.360 billion-$1.366…
benzinga.com Conmed Q3 Adj. EPS $1.04 Beats $1.00 Estimate, Sales $335.557M Miss $336.226M Estimate Conmed (NYSE:CNMD) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.00 by 4 percent. This is a 3.7 percent decrease over earnings of $1.08 per share from…- benzinga.com Piper Sandler Reiterates Neutral on Conmed, Raises Price Target to $45 Piper Sandler analyst Matt O'Brien reiterates Conmed (NYSE:CNMD) with a Neutral and raises the price target from $39 to $45.
- benzinga.com Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46 Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $39 to $46.
- benzinga.com Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est Conmed (NYSE:CNMD) is looking for FY2026 Adj EPS of $4.48-$4.60 vs $4.34 analyst estimate. Narrows FY2026 sales outlook from $1.350 billion-$1.375 billion to $1.358 billion-$1.373 billion vs $1.362…
benzinga.com CONMED Says AirSeal Robotic Solution Is Now Indicated For Use With Intuitive’s 8 mm Hex Cannulas Used As Part Of Intuitive Da Vinci 5 Platform CONMED Corporation (NYSE:CNMD) today announced that its AirSeal® Robotic Solution is now indicated for use with Intuitive’s 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform…
benzinga.com TriCo Bancshares, Verra Mobility, Park Aerospace And Other Big Stocks Moving Higher On Monday US stocks mixed, Dow Jones up 100 pts. TriCo Bancshares up 10% after First Hawaiian buyout. Other gainers: BRAI, VRRM, AIIO, CNMD, HELE, KRO, SM, GFR, GEVO, PARR, OIO, PKE.
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-market session. The company's market cap stands at $213.4 million. China Pharma Holding (AMEX:CPHI) shares…
benzinga.com BMO Capital Initiates Coverage On Conmed with Market Perform Rating, Announces Price Target of $36 BMO Capital initiates coverage on Conmed (NYSE:CNMD) with a Market Perform rating and announces Price Target of $36.- benzinga.com B of A Securities Downgrades Conmed to Underperform, Maintains Price Target to $40 B of A Securities analyst Travis Steed downgrades Conmed (NYSE:CNMD) from Neutral to Underperform and maintains the price target from $40 to $40.
- benzinga.com CONMED Appoints John E. Gallagher CFO, Effective July 15, Succeeding Todd Garner CONMED Corporation (NYSE:CNMD) today announced the appointment of John E. Gallagher as Chief Financial Officer ("CFO"), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with…
- benzinga.com B of A Securities Maintains Neutral on Conmed, Lowers Price Target to $40 B of A Securities analyst Travis Steed maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $52 to $40.
- benzinga.com Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $39 Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $42 to $39.
- benzinga.com JP Morgan Maintains Neutral on Conmed, Lowers Price Target to $40 JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $43 to $40.
- benzinga.com Conmed Raises FY2026 Sales Guidance from $1.345B-$1.375B to $1.350B-$1.375B vs $1.359B Est Conmed (NYSE:CNMD) raises FY2026 sales outlook from $1.345 billion-$1.375 billion to $1.350 billion-$1.375 billion vs $1.359 billion estimate.
- benzinga.com Conmed Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $317.046M Beat $310.507M Estimate Conmed (NYSE:CNMD) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.82 by 8.54 percent. This is a 6.32 percent decrease over earnings of $0.95 per share…
benzinga.com Earnings Scheduled For April 29, 2026 
benzinga.com Clearmind Medicine Submits Patent Application With Intellectual Property Department In Hong Kong Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second…- benzinga.com Earnings Scheduled For January 28, 2026
benzinga.com Earnings Scheduled For November 5, 2025 
benzinga.com Earnings Scheduled For July 30, 2025 
benzinga.com Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Earnings Scheduled For April 30, 2025
- benzinga.com Earnings Scheduled For February 5, 2025
- benzinga.com Top 3 Health Care Stocks That May Dip This Month
- benzinga.com Earnings Scheduled For January 31, 2024 Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
- benzinga.com Earnings Scheduled For October 25, 2023 Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.
- benzinga.com Earnings Scheduled For July 26, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is estimated to report quarterly earnings at $0.87 per share on revenue of $8.97 billion. • Stellantis (NYSE:STLA) is likely to report earnings…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
benzinga.com Earnings Scheduled For April 26, 2023 Companies Reporting Before The Bell • Teck Resources (NYSE:TECK) is expected to report quarterly earnings at $1.36 per share on revenue of $3.11 billion.- benzinga.com Earnings Scheduled For October 26, 2022 Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 517 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 528 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 456 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 529 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For July 27, 2022 Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 329 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's trading, 1214 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 422 stocks made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 126 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
- benzinga.com Earnings Scheduled For May 4, 2022 Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
- benzinga.com Earnings Scheduled For January 26, 2022 Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter.